explore -WSS

explore

author：explore 2025-09-06 05:59:59 - browse：268

The removal of small amounts of brain tissue from desperately ill patients, done as part of a Mount Sinai research project, triggered alarm bells at the Food and Drug Administration and has raised broader questions about the scientific and ethical justification for live-brain research. Journalist and STAT contributor Katherine Eban joins “The Readout LOUD” podcast to discuss the results of a two-year investigation.

Also on this week’s episode, we discuss Novartis’ effort to acquire MorphoSys, and the latest news on Eli Lilly and Novo Nordisk’s blockbuster obesity drugs with Elaine Chen, the newest member of STAT’s biotech reporting team.

For more on what we cover, here’s STAT’s investigation into the Mount Sinai brain-tissue research project; here’s exclusive reporting on the MorphoSys drug at the center of the Novartis acquisition, and Adam Feuerstein’s take on where it might run off the rails; and here’s STAT’s reporting on Novo Nordisk and its weight loss drug Wegovy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Diversity in medical illustrations gets boost from Chidiebere Ibe

entertainment

WSS

Study finds new variant for Parkinson’s in African populations

Psilocybin's anti

Why more medical students aren't specializing in primary care

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Juul spent big to court Black leaders to promote its e

SAMSHA loosens regulations on methadone treatment centers

knowledge

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

Activists slam private health insurers over coverage restrictions

Why more medical students aren't specializing in primary care

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Alkermes shareholders re

Even great ERs can’t make up for American health disparities

Duchenne breakthrough therapy leaves behind pioneering families

Medicare explains how it will choose drugs for negotiation

After affirmative action ruling, medical educators look to 'holistic review'

Cognito secures funding to test medical device for Alzheimer's

hotspot

The real point of Kenneth Smith’s execution by nitrogen gas

How a symptom of dementia informs our understanding of creativity

New Ultima Genomics DNA sequencer can read genome for $100

Why more medical students aren't specializing in primary care

What AAP's gender

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Wikipedia

focus

entertainment

Wikipedia